March 7th 2023
The investigators retrospectively analyzed ABU case log data on 8 different BPH surgical procedures ranging from 2008 to 2021.
December 27th 2022
Dr. Gill discusses clinical impact of the new wave of BPH treatmentsOctober 23rd 2022
In this installment of Urology Times’ 50th Anniversary Innovation Celebration, Bradley Gill, MD, MS, discusses the impact that the new wave of minimally invasive BPH treatments has had for both patients and urologists.
Aquablation for BPH now offered at Hackensack University Medical CenterAugust 30th 2022
"Aquablation therapy is as effective as other minimally invasive treatments [for these men] but with fewer side effects, including only a 10% to 15% risk of retrograde ejaculation," said Ravi Munver, MD.
Dr. Palese discusses same-day discharge following transurethral BPH proceduresApril 8th 2022
“Patients need to understand that even if you tell them that you may be doing this as an ambulatory procedure, they may actually have to stay afterwards, depending on what you find in the operating room or what happens in the postoperative period,” says Michael A. Palese, MD.
Dr. Nickel discusses saw palmetto as a complementary treatment for LUTSMarch 11th 2022
"We shouldn't outright provide a negative attitude to our patients who are looking for alternatives that [serve as] complementary medicine, [like] herbal or phytotherapeutic agents," says J. Curtis Nickel, MD, FRCSC.
Study evaluates same-day discharge for BPH proceduresFebruary 17th 2022
“There's no question that many patients [undergoing transurethral BPH surgery] can be done as a same-day ambulatory procedure. But you need to look at the criteria as to who you're going to keep and who you're not going to keep,” says Michael A. Palese, MD.
Dr. Nickel highlights first 2 parts of pivotal review of saw palmetto in BPHFebruary 2nd 2022
“What's interesting in Dr Strum's analysis of these trials is that he not only looked at the English literature, which many of us are familiar with, but he looked at the many studies done in countries that were published in the non-English literature and never found [their] way into any of our analyses,” says J. Curtis Nickel, MD, FRCSC.
Golden Jubilee: Looking back at 50 years of urology in benign diseasesJanuary 27th 2022
"The devices, telemedicine and remote care, and outpatient surgery risk us losing the human connection we had with the patient, as time spent with them is at a premium today," writes Gopal H. Badlani, MD.
Long-term results of Rezum therapy for patients with large prostatesDecember 23rd 2021
In a recent study, Michael Palese, MD, Evan Garden, and co-authors estimated the long-term outcomes of Rezum water vapor therapy in treating men with large prostates who have benign prostatic hyperplasia.
Rezum therapy: Why it should be considered in large prostatesNovember 29th 2021
“While this study does offer a lot of promise for the treatment options that we can offer to these patients, it does also highlight the need for further prospective trials to evaluate the efficacy of this treatment, as well as the treatments of all the different surgical options available to patients who are suffering from BPH,” says Evan Garden.
Aquablation therapy as a discussion point in patient counselingNovember 26th 2021
“I think the key elements are that you should know about Aquablation if you are treating BPH in consideration for your patients and care, especially those who are looking for a more durable response and to maintain their ejaculation,” says Kevin Zorn, MD, FRCSC, FACS.